ask="2.2400"
ask_size="200"
average_daily_volume="98485"
bid="2.1000"
bid_size="3000"
book_value="1.4000"
change="+0.0403"
change_from_200_day_moving_average="1.2102"
change_from_50_day_moving_average="0.7779"
change_from_52_week_high="-5.6592"
change_From_52_week_low="0.2003"
change_in_percent="+1.8744%"
close="2.1903"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.3000"
ebitda="-2.11M"
eps_estimate_current_year="-0.0200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0200"
ex_dividend_date="N/A"
float_shares="2160000"
high="2.3399"
high_52_weeks="7.8495"
last_trade_date="3/3/2017"
last_trade_price="2.1903"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.1200"
low_52_weeks="1.9900"
market_capitalization="5.87M"
moving_average_200_day="0.9801"
moving_average_50_day="1.4124"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.0000"
open="2.1900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+123.4834%"
percent_change_from_50_day_moving_average="+55.0743%"
percent_change_from_52_week_high="-72.0963%"
percent_change_from_52_week_low="+10.0653%"
previous_close="2.1500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5357"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.1200"
stock_exchange="NCM"
symbol="XTLB"
volume="166830"
weeks_range_52="1.9900 - 7.8495"
